These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Purinergic signaling in kidney disease. Menzies RI; Tam FW; Unwin RJ; Bailey MA Kidney Int; 2017 Feb; 91(2):315-323. PubMed ID: 27780585 [TBL] [Abstract][Full Text] [Related]
6. CNS remyelination as a novel reparative approach to neurodegenerative diseases: The roles of purinergic signaling and the P2Y-like receptor GPR17. Fumagalli M; Lecca D; Abbracchio MP Neuropharmacology; 2016 May; 104():82-93. PubMed ID: 26453964 [TBL] [Abstract][Full Text] [Related]
7. ATPergic signalling during seizures and epilepsy. Engel T; Alves M; Sheedy C; Henshall DC Neuropharmacology; 2016 May; 104():140-53. PubMed ID: 26549853 [TBL] [Abstract][Full Text] [Related]
8. Conversion of extracellular ATP into adenosine: a master switch in renal health and disease. Dwyer KM; Kishore BK; Robson SC Nat Rev Nephrol; 2020 Sep; 16(9):509-524. PubMed ID: 32641760 [TBL] [Abstract][Full Text] [Related]
9. Purinergic signaling negatively regulates activity of an olfactory receptor in an odorant-dependent manner. Yu Y; Zhang C Neuroscience; 2014 Sep; 275():89-101. PubMed ID: 24928349 [TBL] [Abstract][Full Text] [Related]
10. Purine and pyrimidine receptors. Burnstock G Cell Mol Life Sci; 2007 Jun; 64(12):1471-83. PubMed ID: 17375261 [TBL] [Abstract][Full Text] [Related]
11. P2 receptor signaling in neurons and glial cells of the central nervous system. Köles L; Leichsenring A; Rubini P; Illes P Adv Pharmacol; 2011; 61():441-93. PubMed ID: 21586367 [TBL] [Abstract][Full Text] [Related]
12. Purinergic signaling in Alzheimer's disease. Erb L; Woods LT; Khalafalla MG; Weisman GA Brain Res Bull; 2019 Sep; 151():25-37. PubMed ID: 30472151 [TBL] [Abstract][Full Text] [Related]
13. Purinergic receptors in psychiatric disorders. Krügel U Neuropharmacology; 2016 May; 104():212-25. PubMed ID: 26518371 [TBL] [Abstract][Full Text] [Related]
14. Purinergic Regulation of Neutrophil Function. Wang X; Chen D Front Immunol; 2018; 9():399. PubMed ID: 29545806 [TBL] [Abstract][Full Text] [Related]
15. Adenosine and ATP receptors in the brain. Burnstock G; Fredholm BB; Verkhratsky A Curr Top Med Chem; 2011; 11(8):973-1011. PubMed ID: 21401499 [TBL] [Abstract][Full Text] [Related]
16. P2 receptor-mediated signaling in the physiological and pathological brain: From development to aging and disease. Mut-Arbona P; Sperlágh B Neuropharmacology; 2023 Aug; 233():109541. PubMed ID: 37062423 [TBL] [Abstract][Full Text] [Related]
17. Purinergic receptors in embryonic and adult neurogenesis. Oliveira Á; Illes P; Ulrich H Neuropharmacology; 2016 May; 104():272-81. PubMed ID: 26456352 [TBL] [Abstract][Full Text] [Related]
18. Purines and sensory nerves. Burnstock G Handb Exp Pharmacol; 2009; (194):333-92. PubMed ID: 19655112 [TBL] [Abstract][Full Text] [Related]
19. Medicinal chemistry of adenosine, P2Y and P2X receptors. Jacobson KA; Müller CE Neuropharmacology; 2016 May; 104():31-49. PubMed ID: 26686393 [TBL] [Abstract][Full Text] [Related]
20. New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. Baraldi PG; Romagnoli R; Tabrizi MA; Bovero A; Preti D; Fruttarolo F; Moorman AR; Borea PA Farmaco; 2005 Mar; 60(3):185-202. PubMed ID: 15784237 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]